- Home
- / ClearPoint Neuro
ClearPoint Neuro
Stock Price
$13
2024-10-29
Market Capitalization
$363.4 M
2024-10-29
Revenue
$37 M
FY, 2025
ClearPoint Neuro Summary
Company Summary
- Overview
- ClearPoint Neuro (formerly known as MRI Interventions) is a medical device company. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging guidance.
- Type
- Public
- Status
- Active
- Founded
- 1998
- HQ
- Irvine, CA, US | view all locations
- Cybersecurity rating
- ESG rating
Table of Contents
Key People
Pascal E.R. Girin, Director
Ernesto Salegio, Vice President, Segment Leader Translational & Pre-Clinical Research
Lynnette C. Fallon, Director
Operating MetricsView all
Industry Partners
3
Nov, 2019
Patents Issued
95
Nov, 2019
Patent Applications
95
Nov, 2019
LocationsView all
2 locations detected
Irvine, CA HQ
United States
5 Musick
Memphis, TN
United States
40 S Main St
ClearPoint Neuro Financials
Summary Financials
- Revenue (FY, 2025)
- $37.0M
- Gross profit (FY, 2025)
- $22.7M
- Net income (FY, 2025)
- ($25.5M)
- Cash (FY, 2025)
- $45.9M
- EBIT (FY, 2025)
- ($24.2M)
- Enterprise value
- $375.8M